SII, DNDi partner for expanding human trials for dengue treatment
The Pune-based Serum Institute of India (SII) has partnered with Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development organisation, to accelerate the clinical development of a monoclonal...
